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Abstract
Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the molecular mechanisms
regulating the generation of cardiac progenitor cells is not fully understood. We hypothesized that cardiac progenitor cells
are generated from cardiac explant via a process similar to epithelial to mesenchymal transition (EMT).
Methods/Findings: Explant-derived cells were generated from partially digested atrial tissue. After 21 days in culture, c-Kit+
cells were isolated from cell outgrowth. The majority of explant-originated c-Kit+ cells expressed the epicardial marker Wt1.
Cardiac cell outgrowth exhibits a temporal up-regulation of EMT-markers. Notch stimulation augmented, while Notch
inhibition suppressed, mesenchymal transition in both c-Kit+ and c-Kit- cells. In c-Kit+ cells, Notch stimulation reduced,
while Notch inhibition up-regulated pluripotency marker expressions such as Nanog and Sox2. Notch induction was
associated with degradation of b-catenin in c-Kit- cells. In contrast, Notch inhibition resulted in b-catenin accumulation,
acquisition of epitheloid morphology, and up-regulation of Wnt target genes in c-Kit- cells.
Conclusion: Our study suggests that Notch-mediated reversible EMT process is a mechanism that regulates explant-derived
c-Kit+ and c-Kit- cells.
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Introduction
Heart failure after myocardial infarction (MI) is a major public
health issue worldwide. To date, heart transplantation remains the
gold standard for treatment of end-stage heart failure, a procedure
that is limited by donor availability. Cell-based therapy is
emerging as a novel alternative for the treatment of heart failure.
Recently, we and others have demonstrated that cardiac-explant-
derived cells can be generated directly from cardiac biopsies [1–4].
Transplantation of these cells improved cardiac function after MI
[2]. Understanding the molecular mechanisms that controls the
process of cell outgrowth from cardiac explants will assist the
development of more efficient cell-based therapy. For a cell to
become mobile it must undergo a mesenchymal transition [5]. A
well documented form of mesenchymal transition is the epithelial/
endothelial to mesenchymal transition (EMT). EMT is a key step
during embryonic morphogenesis, and is reactivated as a response
to tissue injury and tumor formation in adults [6,7]. Repression of
E-cadherin/VE-cadherin by transcriptional regulators such as
Snail and Slug, (both are members of Snail repressors family) are
the critical step in driving EMT. During development, the
transition of epithelial to mesenchymal phenotype is reversible as
several rounds of EMT and mesenchymal to epithelial transition
(MET) are required for the final differentiation of cells. For
instance, the heart forms through three successive cycles of EMT
and MET [5]. During development, epicardial EMT was shown
to generate cardiovascular progenitor cells that differentiate into
cardiomyocytes [8]. In adults, EMT occurs as a physiological
response to injury. For example, during wound healing,
keratinocytes recapitulate part of the EMT process resulting in
acquisition of an intermediate phenotype, which allows ketarino-
cytes to migrate [9]. More relevant to the current study,
myocardial injury induced re-activation of epicardial cells via
EMT; these cells migrated to the site of injury and contributed to
cardiac regeneration [10,11]. Post-injury epicardial EMT was
associated with the re-expression of embryonic markers such as
Tbx18 and Wt1 [10,12]. At the cellular level, pathological and
physiological EMTs were similar, in that they were governed by
similar signaling pathways, regulators, and effector molecules.
These pathways include TGF-b, Wnt/b-catenin, Notch, Hedge-
hog, and others [13,14]. Among them, the Notch pathway
appeared to promote cardiac gene expression and myocyte
differentiation [15,16]. A similar procardiogenic action of Notch
had been reported in mesenchymal cells, which was possibly
a reiteration of the EMT that occurred during embryonic cardiac
development [17].
Here we determined that explant-derived cells undergo EMT-
like changes in culture. Our data demonstrated that mesenchymal
phenotype of explant derived cells is reversible, and is regulated by
Notch signaling. We also showed that pluripotent gene expressions
in c-Kit+ cells are regulated by Notch. Overall our findings suggest
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outgrowth phenotype in vitro. These new insights into the
molecular mechanisms of the cardiac progenitor cells regulation
in vitro will help define the development of a more efficient cell-
based therapy for heart failure.
Materials and Methods
Generation of Explant-derived Cells
Animal studies were performed in a facility accredited by
American Association for Accreditation of Laboratory Animal
Care. Animal studies were performed in accordance with federal
laws and regulations, international accreditation standards, and
institutional policies including approval by the Animal Care and
Use Committee of Banner Sun Health Research Institute (IACUC
protocol #10-03). Atrial tissue was obtained from 3 month old
male Harlan Sprague Dawley rats. Cardiac explant outgrowth was
generated as previously described [1,2]. Briefly, tissue was cut into
1–2 mm
3 pieces and digested with 0.2% trypsin (Invitrogen,
Carlsbad, CA) and 0.1% collagenase IV (Invitrogen) for 10
minutes. The remaining tissue fragments were cultured as
‘‘explants’’ in explants medium (EM) which was composed of
IMDM supplemented with 10% fetal bovine serum (FBS), 100 U/
ml penicillin G, 100 mg/ml streptomycin, 2 mmol/L L-glutamine,
and 0.1 mmol/L 2-mercaptoethanol. For the time course experi-
ments, digested tissue was placed one piece per well into poly-L-
lysine (PLL)-coated cell culture plates to facilitate adhesion. After
a few days in culture, a layer of cardiac stromal cells grew out of
the adherent explants, over which small phase-bright cells were
formed. After 21 days in culture, Cells were collected by pooling
two washes of Ca
2+-Mg
2+-free PBS supplemented with
0.53 mmol/L EDTA and one wash of 0.25% Trypsin-
0.53 mmol/L EDTA in PBS for 5 min. Combined washes were
centrifuged at 2006g for 5 min and the cell pellet was collected.
C-Kit+ population was separated from the cell outgrowth using
magnetic beads (MACS, Miltenyi Biotec) according to manufac-
turer protocol and was analyzed by flow cytometry to confirm the
purity.
Transfection of Notch intracellular Domain (NICD)
Freshly isolated c-Kit- and c-Kit+ cells were plated separately at
1610
5 cells per well in EM media in 12 well-plates. The next day
cells were transfected with an adenovirus vector coding Notch
intracellular domain (NICD) and enhanced green fluorescent
protein (eGFP) (generous gift of Dr. M. Sussman, University of
California; originally created by Dr. Tezuka [18]). Control cells
were transfected with adenovirus carrying eGFP only. Trans-
fection efficiency of .90% was confirmed by GFP expression.
Cells were collected at day 7 after transfection.
Cell Treatment with c-secretase Inhibitor
Freshly isolated c-Kit- and c-Kit+ cells were plated at 1610
5
cells per well in EM media. c-Secretase inhibitor XXI (GSI)
(Calbiochem) was dissolved in DMSO and was added to cell
culture media at the final concentration of 10 nM. Cells were
treated for 7 days. Control cells were treated with DMSO (0.005%
final concentration).
Immunostaining and Cell Quantification
For the time course experiments, explants were cultured for 4, 8
and 21 days. Explant tissue was removed and cells were fixed/
permeabilized in a 1:1 mixture of acetone/100% ethanol. For c-
Kit surface labeling cells were fixed with 4% paraformaldehyde.
Cells were blocked with 3% BSA in PBS and stained with primary
antibody (Table S1). Corresponding secondary antibodies were
conjugated with Alexa-488 or Alexa 568 (Molecular Probes).
Nuclei were stained with DAPI, 49 6-diamidino-2-phenylindole
(Invitrogen).
For cell quantification, the number of cells was counted in ten
random microscopic fields for each antigen. The percentage of
antigen-positive cells was calculated as a number of positively-
stained cells normalized to the total number of cells. For the 8 and
21 day time points, at least 2000 cells total were counted in each
case. For the 4-day time point, 200–600 cells were counted in each
case due to the low number of explant-derived cells at this early
time point.
Immunostaining of Heart Sections
Heart tissue was embedded in tissue frozen media (Triangle
Biomedical Science) snap-frozen in liquid nitrogen and sectioned
coronally using Leica CM1900 cryostat (Leica Microsystems,
Bannockburn, IL). Coronal tissue sections (5–7 mm thickness) were
mounted on positively charged glass slides, and fixed/permeabi-
lized in a 1:1 mixture of acetone/100% ethanol. For immunoflu-
orescent staining, fixed tissue sections were blocked with 3% BSA
in PBS and incubated with primary antibodies (Table S1). Specific
staining was visualized using corresponding secondary antibodies
conjugated with Alexa 488 or Alexa 568 (Molecular Probes).
RNA Isolation and Quantitative Real-time RT-PCR
Total RNA was extracted from total outgrowth, c-Kit+ or c-Kit-
cells using RNAspin mini isolation kit (GE Healthcare). RNA
integrity and concentration were assessed on the Agilent 2100
Bioanalyzer with RNA 6000 Nano LabChip kit (Agilent Tech-
nologies Inc). Total RNA (100 ng) was reverse transcribed with
QuantiTect Reverse Transcription kit (Qiagen). Real time RT-
PCR was conducted using the Rower SYBR Green Master Mix
(Applied Biosystems) on a StepOnePlus Real-time PCR System
(Applied Biosystems). Specific primers were synthesized by
Invitrogen (sequences are available upon request). b-Actin was
used as a reference gene. Data analysis was performed on StepOne
software version 2.1 (Applied Biosystems) using the comparative
Ct ( DDCt) quantitation method.
Western Blotting
Cells were lysed in RIPA buffer (Thermo Scientific) containing
Halt Phosphatase and Proteinase inhibitor cocktail (Thermo
Scientific) according to the manufacturer protocol. Protein
concentration was determined using BCA Protein Assay kit
(Thermo Scientific). Equal amount of protein (50 mg) was loaded
in each well of 10% Tris-Glycine gel (Bio-Rad Laboratories) and
subjected to electrophoresis. Proteins were transferred to PVDF
membrane (Invitrogen), and then blocked with 5% non-fat dry
milk in Tris buffered saline (TBS) followed by overnight
incubation with primary antibodies at 4uC. Membranes were
washed in TBS containing 0.05% Tween 20. Corresponding horse
radish peroxidase (HPR)-conjugated anti rabbit or anti mouse
IgGs (Invitrogen) were used as secondary antibodies. Blots were
probed with an anti b-actin antibody as a loading control.
Immunoreactive proteins were detected by chemiluminescence
(Thermo Scientific). Band intensity was determined using
FluorChem 8900 software (Alpha Innotech Corp).
Flow Cytometry
Cells were fixed in 70% ethanol and labeled with the following
antibodies: c-Kit, E-cadherin (Santa-Cruz Biotechnology), MHC,
SMA, (Abcam) and cleaved caspase 3 (Cell signaling Tech). Cells
EMT and Notch in Cardiac c-Kit+ Cells
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anti-rabbit or anti-mouse IgG conjugated with Alexa-488,
phycoerythrin (PE) or PE-Cy5.5 (Invitrogen). For a negative
control, cells were labeled with isotype IgG instead of primary
antibody. Cell events were detected using FACS Calibur flow
cytometer equipped with argon laser (BD Biosciences). Data was
analyzed using CellQuest software (BD Biosciences).
Proliferation Assay
Cells were labeled with 10 mM BrdU for 40 min. Cells were
harvested and fixed with 70% ethanol, following with the
treatment of 30 mg DNAse I for 1 h to denature DNA, and then
incubated with anti-BrdU antibody conjugated with Fluorescein
isothiocyanate (FITC). Cell events were detected using FACS
Calibur flow cytometer equipped with argon laser (BD Bios-
ciences). Data was analyzed using CellQuest software (BD
Biosciences).
Imaging
Images were captured at room temperature using Olympus IX-
51 epifluorescence microscope equipped with a DP72 device
camera. The following excitation/emission maximum filters:
490 nm/520 nm, 570 nm/595 nm and 355 nm/465 nm, were
used for image acquisition. Images were processed using DP2-
BSW software (Olympus Corp). Acquisition settings were held
constant within each experiment.
Statistics
All data was represented as mean 6 S.E. Significance (p,0.05)
was determined using Student’s t-test for unpaired samples or
directional Wilcoxon test. Statistical analysis was conducted using
SigmaStat 3.5 software.
Results
Mesenchymal Transition of Cardiac Cell Outgrowth in
Culture
Cardiac explant outgrowth was generated from partially
digested atrial tissue as previously reported by our laboratory
and others [1–4]. We monitored temporal changes in EMT
markers in these cells at 4, 8, and 21 days in culture using
immunocytochemistry (Figure 1 A, B). We found that the
percentage of cells expressing epithelial markers E- cadherin (E-
cad) and Wilms tumor 1 (Wt1) [11,19] decreased in culture
(3266.2% vs. 4.561.2% for E-cad, and 61.565.3% vs. 4963.%
for Wt1 at day 4 vs. day 21, respectively). The percentage of cells
expressing mesenchymal cell marker a-smooth muscle actin
(SMA) increased (from 10.163.4% to 31.963.5% at day 4 vs.
day 21 respectively), while, the percent of c-Kit+ progenitor cells
remained relatively unchanged during the indicated times
(23.868.1% vs. 2964.4% day 4 vs. day 21). In addition, gene
expression of Snail, a well-described EMT marker, was increased
with time in culture (Figure 1C). Taken together, our data suggest
that cardiac cell outgrowth undergo an EMT-like process in
culture. To determine whether this temporal increase in mesen-
chymal marker may be due to selective high proliferation and/or
diminished apoptosis of fibroblasts, we measured both cell
proliferation and apoptosis. After 21 days in culture, BrdU
incorporation rate was similar for c-Kit+, E-cad+ and SMA+ cells
(51.066.4%, 41.868.4%, and 34.0611.1% respectively)
(Figure 1D, Figure S1) suggesting that fibroblast proliferation rate
did not exceed that of other cell sub-population in culture. We also
examined the level of apoptosis on cell outgrowth by double-
labeling with antibodies to cell–specific markers and to activated
(cleaved) caspase-3. All studied cell sub-populations displayed
similar levels of cleaved caspase 3 (3.560.5%, 3.661.6% and
4.560.6%, for c-Kit+, E-cad+, and SMA+ cells respectively)
(Figure 1E, Figure S1). Collectively, these results suggested that the
temporal increase in mesenchymal markers is unlikely due to
selective proliferation and/or diminished apoptosis of fibroblasts
but rather due to EMT.
Characterization of Explant-originated c-Kit+ Cells
Using flow cytometry, we found 74+8.6% of c-Kit+ cells, while
only 49+3.4% of total cardiac outgrowth expressed Wt1,
suggestive of epicardial origin (Figure 2A,B) [11,19]. Next we
questioned whether or not Wt1+/c-Kit+ cells are present in atrial
tissue in vivo. To answer that, whole heart coronal sections were
analyzed by immunohistochemistry. We found that Wt1+ cells
were located in a thin layer of epicardial cells of both right and left
atria of normal hearts (Figure 2C–D), while c-Kit+ cells were
found primarily within the sub-epicardium and myocardium albeit
at low frequency (Figure 2C–D). No overlap was observed
between c-Kit+ and Wt1+ cells in the atrium (Figure 2C–D).
This result indicates that epicardial Wt1+ cells within the atrium
do not express c-Kit marker in vivo, but more likely they acquired
c-Kit+ phenotype in culture.
Next, to determine if c-Kit+ and c-Kit- cells expressed EMT
and pluripotency markers differently in culture, we sorted cell
outgrowth based on c-Kit expression at 21 days in culture. Purity
of c-Kit+ and c-Kit- cells was confirmed by FACS and
immunocytochemistry (Figure 2E and Figure S2, respectively).
Gene expression profile of c-Kit+ and c-Kit- cell populations were
analyzed by qRT-PCR. We found c-Kit+ cells expressed higher
levels of the EMT marker Slug (also known as Snail 2) and
pluripotency markers Nanog and Sox2 (Figure 2F), while no
differences were found in other EMT markers, Snail and N-
cadherin (N-cad) compared to c-Kit- cells (Figure 2F). These data
indicate that both c-Kit- and c-Kit+ cells underwent EMT-like
process in culture. Furthermore, c-Kit+ cells expressed signifi-
cantly higher gene expression levels of Notch1 and Hey1, a direct
down-stream target of Notch, compared to c-Kit- cells (Figure 2F)
[20].
Next, to determine whether or not Notch-active c-Kit+ cells
may interact with c-Kit- cells in culture, we labeled c-Kit+ and c-
Kit- cells with either Notch1 or Jagged1. We found that Notch1
was mainly expressed in c-Kit+ population, while Jagged1 was
mainly observed in c-Kit- cells (Figure 3 A–C). Notch1+/c-Kit+
cells were also positive for either myosin heavy chain (MHC) or
fibroblast specific factor 1 (FSP1), while in c-Kit- cells, Jagged1 was
co-localized with either FSP1 or SMA, (Figure 3 A–C). These data
suggest that Notch1+/c-Kit+ cells in cardiac outgrowth may be
stimulated by cell contacts with Jagged1+/c-Kit-, which is
consistent with previous reports indicating that Notch requires
a direct contact between a receptor-expressing and a ligand-
expressing cell to elicit an inductive signal [21].
Notch Suppression Delays Cardiac Explant Outgrowth
Notch signaling is known to regulate EMT of epicardial cells
[22], therefore to determine whether or not EMT plays a role in
c-Kit+ generation within cardiac cell outgrowth, we suppressed
EMT using Notch inhibitor, c-secretase inhibitor XXI (GSI) and
examined the effects on cell outgrowth and c-Kit+ formation. We
observed that GSI treatment resulted in significant delay in cell
outgrowth compared to control. At 4 days in culture, 85% of
control explants and 20% of GSI-treated explants (out of 20
examined) attached to the plate and started to generate cells
(Figure S3). By 8 days, all of the control explants attached and
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explants attached and produced significantly less cells compared
to controls. After 21 days in culture, cells generated in the
presence of GSI exhibited epithelioid cobblestone-like morphol-
ogy (Figure S3). GSI treatment tend to increase the number of c-
Kit+ cells in cell outgrowth (from 22.867% to 40613.6%
Figure 1. Expression of cell-specific markers in cardiac cell outgrowths is time-dependent. (A) Cell outgrowths were cultured for various
times and analyzed by immunofluorescence for the expression of cell lineage markers: stem cell marker, c-Kit; cardiac structural proteins, a-myosin
heavy chain (MHC); mesenchymal cell marker, a-smooth muscle actin (SMA), epithelial cell marker, E-cadherin (E-cad) and epicardial progenitor
marker Willms tumor 1 (Wt1). Nuclei were counterstained with DAPI (blue). (B) Percentage of cells expressing cell lineage markers. * p,0.05,
compared to day 4. (C) Temporal changes of Snail gene expression were measured by qRT-PCR; *, p,0.05 compared to day 4. (D) Proliferation of
outgrowth sub-populations. Proliferating (BrdU-positive) marker-specific outgrowth sub-populations were detected by flow cytometry as double
positive events. The percentage of marker-specific proliferating cells was calculated as number of BrdU+/marker+ cells normalized to the total
number of marker+ cells. (E) Apoptosis of cell sub-populations. Apoptotic (cleaved caspase 3-positive) marker-specific outgrowth sub-populations
were detected by flow cytometry as double positive events. The percentage of marker-specific apoptotic cells was calculated as a number of caspase-
3+/marker+ cells normalized to the total number of marker+ cells.
doi:10.1371/journal.pone.0037800.g001
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37800Figure 2. Characterization of c-Kit+ cells isolated from total outgrowths. (A) Flow cytometry analysis of outgrowths cultured for 21 days
shows percent of Wt1+ cells. (B) FACS analysis of double c-Kit and Wt1 labeling. Percentage of c-Kit+/Wt1+ cells indicated in upper right quadrant of
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to 54.167.4% control vs. GSI-treated; Figure S4). Taken
together these data indicate that Notch suppression delays
outgrowth, promotes epithelial morphology, and tend to increase
the formation of c-Kit+ cells in culture.
Notch Signaling Regulates Mesenchymal Transition of c-
Kit+ and c-Kit-cells
To determine whether or not Notch signaling also regulate
mesenchymal transition in c-Kit+ and c-Kit- cells, Notch was
stimulated by adenoviral mediated gene transfer of Notch
intracellular domain fused with GFP (NICD-GFP) and inhibited
by GSI in both cell populations (Figure 4A). Modulation of Notch
was validated by immunostaining, Western blot and qRT-PCR.
Western blot analysis with activated Notch intracellular domain
antibody (Val1744) showed that the amount of NICD is
significantly increased in virus-transfected cells (Figure 4B). NICD
was undetectable in control c-Kit- cells or in cells treated with GSI.
Quantitative RT-PCR analysis confirmed that the expression level
of down-stream Notch target gene Hey1 was significantly in-
creased in NICD-transfected cells (Figure 4C). We found that in c-
Kit+ cells, NICD over-expression increased Slug, while decreased
Nanog gene levels. In contrast, suppression of Notch signaling
significantly up-regulated expression of Nanog, Sox2 and Wt1
(Figure 4D). However, the cardiomyocyte marker MHC increased
in both c-Kit+ and c-Kit- cells. (Figure 4D). FACS analysis showed
that NICD over-expression increased SMA-positive cells
(1764.1% to 3566.1% in c-Kit+ cells, and from 3666.1% to
56.667.4% in c-Kit- cells, control vs. NICD-over-expressed
respectively) and MHC-positive cells (31.062.4 to 47.367.4% in
c-Kit+ cells and 18.765.1 to 39.868.2% in c-Kit- cells). The
number of E-cadherin-positive cells was moderately decreased by
Notch stimulation (4.561.25% to 3.861.4% in c-Kit+ cells, and
4.661.4% to 2.060.7% in c-Kit- cells) (Figure 4E, F; Figure S5,
Tables S2 and S3). In contrast, Notch suppression increased E-
cadherin-positive cells in both c-Kit+ and c-Kit- populations
(4.561.25% to 7.962.6% in c-Kit+ cells and 4.661.4% to
11.262.2% in c-Kit- cells). GSI treatment decreased MHC-
positive cells in c-Kit+ population (3162.4% to 21.164.2%,
control vs. GSI-treated) and had no effect on c-Kit- cells (18.765.1
vs. 21.267.0%). The number of SMA-positive cells remains
relatively unchanged in GSI-treated cells compared to control
(17.564%. vs.18.964.49% in c-Kit+ cells and 3666.1% vs.
31.367.2% in c-Kit- cells ) (Figure 4E, F; Figure S5, Tables S2
and S3). In addition, suppression of Notch induced morphological
changes in explant-originated cells. While NICD –over-expressed
cells displayed a spindle-shaped appearance, GSI-treated cells
acquired an epithelioid cobblestone-like morphology (Figure 5A).
Using immunocytochemistry we showed that acquisition of
epitheloid morphology was associated with reduction in N-
cadherin, induction of epithelial marker E-cadherin and up-
regulation of membrane-associated b-catenin (Figure 5B, Figure
S6).Taken together the results of qRT-PCR, flow cytometry and
immunostaining indicate that Notch stimulation promoted mes-
enchymal transition and differentiation of c-Kit+ and c-Kit- cells,
while Notch suppression reversed mesenchymal transition. In c-
Kit+ cells, Notch suppression also up-regulated the expression of
pluripotency genes.
Notch and Wnt/b-catenin Crosstalk
Wnt/b-catenin cascade was recently reported to pay a role in
EMT [23,24]. Therefore, we asked whether or not Wnt/b-
catenin is involved in Notch-modulated EMT via in c-Kit+ and
c-Kit- cells. Compared to c-Kit-, we found that c-Kit+ cells
express significantly higher levels of Wnt3a, gene coding ligand,
Cyclin D1 and Cyclin D2, genes coding direct targets of
canonical Wnt/b-catenin signaling (Figure 6A), suggesting that
canonical Wnt/b-catenin signaling is more active in c-Kit+
compared to c-Kit- cells. Two major components of canonical
Wnt cascade are b-catenin and glycogen synthase kinase 3b
(GSK3b). GSK3b phosphorylates b-catenin and targets it to
degradation, which ultimately maintains Wnt signaling at a low
level. Inactivation of GSK3b results in accumulation and/or
nuclear translocation of b-catenin. Nuclear b-catenin serves as
a transcriptional factor promoting transcription of Wnt target
genes [25]. In addition b-catenin regulates cell adhesion via
interaction with E-cadherin. To examine more closely the state
of Wnt signaling, we performed Western blot with antibodies
against total GSK3b, inactive (Ser9 phosphorylated) GSK3b
(pGSK3b), total b-catenin and transcriptionally active (Ser37
dephosphorylated) b-catenin. At the base level, we found no
significant differences in the pGSK3b/total GSK3b ratios and
in the protein levels of total and active b-catenins between c-
Kit+ and c-Kit- cells (Figure S7). NICD treatment reduced
pGSK3b/total GSK3b protein ratio in c-Kit+ cells, while no
change were found in the levels of active and total b-catenin
proteins. In c-Kit- cells, NICD treatment significantly reduced
the levels of active and total b-catenin (Figure 6B–D). In
contrast, Notch inhibition increased total b-catenin in c-Kit-
cells (Figure 6B–D). Accumulated b -catenin in GSI-treated c-
Kit- cells mostly presented in cytosolic/membrane-associated
forms and possibly contributed to MET through interaction
with E-cadherin (Figure 5). Furthermore, GSI treatment resulted
in up-regulation of Wnt target genes Cyclin D1 and Cyclin D2
in c-Kit- cells (Figure 6E). In contrast, no significant changes in
expression levels of Wnt target genes were found in GSI- or
NICD- or treated c-Kit+ cells. In summary, these data showed
that in c-Kit- cells Notch induction is associated with
degradation of b-catenin, while Notch down-regulation stimu-
lated b-catenin accumulation followed by up-regulation of Wnt
target genes, indicating a negative feedback between Notch and
Wnt/b-catenin signaling in these cells.
Discussion
Here we showed that explants-derived cells underwent
spontaneous EMT-like process in culture, during which c-Kit+
cells were generated. Furthermore, we showed that Notch
activation in c-Kit+ cells further promoted EMT, while its
suppression reversed EMT process leading to an activation of
pluripotent genes. This EMT observation is supported by an
histogram was calculated as a ratio of c-Kit+/Wt1+ (UR) to the total number of c-Kit+ cells (UR + LR). (C–D) Heart coronal sections are labeled with anti
c-Kit (red) or anti Wt1 (green) antibodies. Nuclei were stained with DAPI (blue). Right column represents merged images of consecutive sections
labeled with c-Kit and Wt1. (C) Representative images of left atrium are shown. Scale bar, 100 mm. (D) Higher magnification of the area selected in the
box. Scale bar, 20 mm. (E) Purity of c-Kit+ and c-Kit- cell populations were confirmed by FACS analysis. C-Kit+ (black) and c-Kit- (blue) cells were
labeled with anti-c-Kit antibody followed by secondary antibody conjugated with Alexa 488. For negative control, isotype IgG was used instead of
primary antibody (grey). Representative histogram is shown. (F) qRT-PCR analysis of c-Kit+ and c-Kit- cell populations. Expression levels were
normalized to the level of b-actin, fold changes were calculated as a ratio of expression in c-Kit- group to expression in c-Kit+ group, * p,0.05.
doi:10.1371/journal.pone.0037800.g002
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37800Figure 3. Expression of Notch1 receptor and Jagged1 in c-Kit+ and c-Kit- cells. (A) c-Kit+ cells displayed positive staining for Notch1 (green)
co-localized with MHC (red, top row) or FSP1 (red, bottom row). (B) C-Kit- cells displayed positive staining for Jagged (green) co-localized with FSP1
(red, top row) or SMA (red, bottom row) as indicated. (C) Low number of c-Kit+ cells also express Jagged1 (green) co-localized with FSP1 (red). (A–C)
Scale bar, 20 mm.
doi:10.1371/journal.pone.0037800.g003
Figure 4. Notch signaling regulates mesenchymal transition of c-Kit+ and c-Kit- cells. Notch signaling was up-regulated by over-
expressing NICD-GFP adenovirus or suppressed with c-secretase inhibitor XXI (GSI). (A) NICD transfection efficiency was monitored by GFP
expression. (B) Notch modulation was confirmed by a Western blot analysis with anti-NICD antibody and (C) by qRT-PCR measuring expression level
of Hey1. (D) qRT-PCR expression analysis after Notch signaling modulation. Expression levels were normalized to the level of b-actin. Fold changes
were calculated as a ratio of expression in experimental (NICD- or GSI-treated) group to the expression in control group, * p,0.05. (E, F) FACS
analysis of c-Kit+ (E) and c-Kit- (F) cells after Notch signaling modulation. N=5 per group, *, p,0.05 compared to control.
doi:10.1371/journal.pone.0037800.g004
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37800Figure 5. Suppression of Notch reversed mesenchymal phenotype of explant-derived cells. C-Kit+ and c-Kit- cells were cultured in
presence of GSI. Representative images of c-Kit- cells are shown. (A) Transmitted light images demonstrate changes in cell morphology upon
treatment with NICD or GSI. (B) Cells were labeled with antibodies to E-cadherin (white), N-cadherin (red) or b-catenin (green) as indicated. Nuclei
were counterstained with DAPI (blue). Scale bars, 100 mm (A) or 20 mm (B).
doi:10.1371/journal.pone.0037800.g005
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37800Figure 6. Notch modulation affects state of Wnt signaling. (A) Comparative qRT-PCR analysis of selected Wnt signaling-related genes in c-Kit+
and c-Kit- cells. (B–E) Notch signaling was up-regulated by over-expressing NICD-GFP adenovirus or suppressed with GSI. (B–C) Western blot of
selected Wnt cascade components. b-Actin was used as a loading control. Representative images are shown. (D) Density of specific bands were
quantified and normalized to the density of beta-actin. Level of inactive GSK3b was determined as ratio between pGSK3b (Ser 9) and total GSK3b.( E)
qRT-PCR analysis of selected Wnt target genes in NICD-treated or GSI-treated cells. N=5 per treatment condition. *, p,0.05.
doi:10.1371/journal.pone.0037800.g006
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37800increase in SMA+ cells, an increase in Snail gene expression,
and a decrease in E-cadherin+ cells. This phenomenon cannot
be explained by selective proliferation, and/or diminished
apoptosis of fibroblasts, or differentiation of c-Kit+ cells to
fibroblasts for the following reasons: 1) proliferation and
apoptosis rates of progenitor cells and fibroblasts are similar;
and 2) the number of progenitor c-Kit+ cells in the cell
outgrowth remained relatively stable (Figure 1B, D, and E). The
more likely explanation of the spontaneous EMT is to the
release of EMT modulators such as TGF-b and/or cell-to–cell
interaction between c-Kit+ cells and fibroblasts in culture. This
explanation is consistent with previous reports indicating that
epicardial EMT can be induced by activation of TGF-
b signaling [26,27] and epicardial cells undergo spontaneous
EMT when cultured in the presence of fibroblasts [28,29].
Furthermore, we found that approximately 50% of total
outgrowth and 74% of c-Kit+ cells expressed Wt1 indicating their
epicardial origin [30]. This finding is in agreement with reports
showing that during development and in adult hearts after
infarction, epicardial cells gave rise to cardiovascular progenitors
through EMT [19,31–33]. Here we found that, in native atria,
epicardial cells are negative for c-Kit, while explant-derived c-Kit+
cells express epicardial marker Wt1 as well as pluripotency
markers Nanog and Sox2 (Figure 2). Our results are consistent
with accumulating evidences showing that mesenchymal pheno-
type of cells generated by EMT may represent a transient
microenvironment-dependent cell state that accompanied by re-
activation of fetal gene program and transformation of somatic
cells to pluripotent state [34–37].
We found that Notch 1 receptor was expressed mainly in c-Kit+
cells, while Jagged 1 is expressed mainly in c-Kit- cells. These data
suggest that in cell outgrowth, c-Kit- cells may stimulate Notch
signaling in c-Kit+ progenitors via direct cell-to-cell contacts
leading to mesenchymal transition and/or pluripotency gene re-
activation. This observation is in agreement with reports in-
dicating that Notch signaling stimulates EMT of epicardial-
derived cells [21,22] and maintain pluripotency in cardiac resident
progenitor cells [38]. We found that suppression of Notch
signaling significantly delayed cell migration out of explants and
increased the percentage of c-Kit+ cells, probably due to partial
inhibition of EMT in culture (Figures S3 and S4). In both c-Kit+
and c-Kit- cells activation of Notch stimulation promoted cell
transition toward the mesenchymal phenotype, as indicated by
increased numbers of SMA+ cells, and decreased numbers of E-
cadherin+ cells. In contrast, Notch suppression reversed the
mesenchymal transformation of these cells and led to epithelial-like
changes in cell morphology more profoundly in c-Kit- cells
(Figure 4D–F, Figure 5). Notch inhibition was associated with
further up-regulation of Nanog and Sox2 pluripotency genes only
in c-Kit- cells. One may hypothesize that, in c-Kit+ cells, Notch
functions as a gatekeeper, providing a fine regulation of these
pluripotency genes. Additional studies are needed to elucidate this
hypothesis.
Our data indicates that in c-Kit- cells Wnt/b-catenin
signaling is involved in EMT regulation via negative feedback
with Notch signaling. This is consistent with previous studies
showing that Wnt/b-catenin cascade plays a role in epicardial
EMT regulation [23]. However, in c-Kit+ cells NICD over-
expression led to only a slight reduction in the active b-catenin
protein level and had no effect on the total b-catenin protein
level and the expression level of Wnt target genes (Figure 6B–
E). In addition, no effects were observed when Notch signaling
was inhibited in c-Kit+ cells (Figure 6B–E). The lack of Notch
modulation effect on Wnt/b-catenin cascade in c-Kit+ cells may
suggest that in these cells Wnt cascade is regulated indepen-
dently of Notch. Another possible explanation is that Wnt
pathway lies up-stream to Notch signaling.
In conclusion, the presented study demonstrates that cardiac
explant outgrowth underwent an EMT-like process in culture.
Notch activation promoted this process, while Notch suppres-
sion resulted in EMT reversal. In addition, Notch suppression
led to an increase in number of c-Kit+ cells and stimulated
pluripotency gene expression only in c-Kit+ cells. These data
are useful for optimizing the scaled-up production and
phenotype modulation of progenitor cells needed for clinical
applications.
Supporting Information
Figure S1 Proliferation (A) and apoptosis (B) in cardiac
outgrowth sub-populations. (A) ECDs were treated with
BrdU following by labeling with anti-BrdU antibody conjugated
with Alexa-488 and lineage specific antibodies conjugated with
PE. Double positive events were detected by flow cytometry. (B)
Apoptosis of EDCs sub-populations. EDCs were labeled with anti-
activated caspase-3 antibody conjugated with Alexa-488 and
lineage specific antibodies conjugated with PE. Double positive
events were detected by flow cytometry. Representative histo-
grams are shown.
(TIF)
Figure S2 Purity of c-Kit+ (A) and c-Kit- (B) cell subsets
were confirmed by immunocytochemistry. Cells were
labeled with anti c-Kit antibody followed by secondary antibody
conjugated with Alexa 488 (green). Scale bar, 20 mm.
(TIF)
Figure S3 Cardiac explants cultured in presence of GSI
exhibited significant delay in generation of cell out-
growth. N=20.
(TIF)
Figure S4 GSI addition to explant in explant culture
media induced expression of c-Kit and Wt1 markers in
EDCs. EDCs derived from control and GSI-treated (GSI)
explants were collected 21 days after culturing and subjected to
flow cytometry.
(TIF)
Figure S5 C-Kit+ and c-Kit- cells were treated to up-
regulate (NICD) or suppress (GSI) Notch signaling and
analyzed by flow cytometry. FACS analysis of control (black),
NICD- (blue) and GSI-treated cells (green). Representative
histograms are shown. For a negative control, isotype IgG was
used instead of primary antibody (grey).
(TIF)
Figure S6 Suppression of Notch reversed mesenchymal
phenotype of C-Kit+ cells. GSI was added to cell culture
media to suppress Notch signaling. Representative images of c-
Kit+ cells are shown. (A) Transmitted light images demonstrate
changes in cell morphology upon treatment with NICD or GSI.
(B) Cells were labeled with antibodies to E-cadherin (green), N-
cadherin (red) or ?-catenin (green) as indicated. Nuclei were
counterstained with DAPI (blue). Scale bars, 100 mm (A) or 20 mm
(B).
(TIF)
Figure S7 Western blot analysis of Wnt signaling
components in c-Kit+ and c-Kit- cells. Density of specific
bands were quantified and normalized to the density of beta-actin.
EMT and Notch in Cardiac c-Kit+ Cells
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37800Level of inactive GSK3b was determined as ratio between
pGSK3b (Ser 9) and total GSK3b.N=5 .
(TIF)
Table S1 Primary antibodies. ICC, immunocytochemistry;
IHC, immunohistochemistry; FC, flow cytometry; WB, Western
blotting.
(DOCX)
Table S2 Gene expression analysis of Notch modulated
c-Kit+ and c-Kit- cells. Q Gene expression significantly
decreased compared to control; q Gene expression significantly
increased compared to control; « No significant differences.
(DOCX)
Table S3 FACS analysis of Notch-modulated c-Kit+ and
c-Kit- cells. Q Gene expression significantly decreased com-
pared to control; q Gene expression significantly increased
compared to control; « No significant differences.
(DOCX)
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